AstraZeneca PLC (AZN)
USD 64.64
(-3.78%)
USD 64.64
(-3.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 37.54 Billion USD | 17.47% |
| 2022 | 31.96 Billion USD | 27.94% |
| 2021 | 24.98 Billion USD | 17.18% |
| 2020 | 21.31 Billion USD | 9.53% |
| 2019 | 19.46 Billion USD | 13.46% |
| 2018 | 17.15 Billion USD | -5.47% |
| 2017 | 18.14 Billion USD | -3.86% |
| 2016 | 18.87 Billion USD | -5.91% |
| 2015 | 20.06 Billion USD | -0.94% |
| 2014 | 20.25 Billion USD | -0.96% |
| 2013 | 20.45 Billion USD | -9.43% |
| 2012 | 22.58 Billion USD | -18.08% |
| 2011 | 27.56 Billion USD | 2.55% |
| 2010 | 26.88 Billion USD | -0.55% |
| 2009 | 27.02 Billion USD | 8.1% |
| 2008 | 25 Billion USD | 6.15% |
| 2007 | 23.55 Billion USD | 12.62% |
| 2006 | 20.91 Billion USD | 12.49% |
| 2005 | 18.59 Billion USD | 14.54% |
| 2004 | 16.23 Billion USD | 12.89% |
| 2003 | 14.38 Billion USD | 7.9% |
| 2002 | 13.32 Billion USD | -43.46% |
| 2001 | 23.57 Billion USD | 30.11% |
| 2000 | 18.11 Billion USD | -1.74% |
| 1999 | 18.43 Billion USD | 101.57% |
| 1998 | 9.14 Billion USD | 6.52% |
| 1997 | 8.58 Billion USD | -6.51% |
| 1996 | 9.18 Billion USD | 21.35% |
| 1995 | 7.56 Billion USD | 8.06% |
| 1994 | 7 Billion USD | 6.64% |
| 1993 | 6.56 Billion USD | 8.83% |
| 1992 | 6.03 Billion USD | -17.91% |
| 1991 | 7.35 Billion USD | 0.04% |
| 1990 | 7.34 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 9.79 Billion USD | 2.81% |
| 2024 Q1 | 9.53 Billion USD | 7.67% |
| 2023 Q3 | 9.39 Billion USD | -0.62% |
| 2023 Q4 | 9.71 Billion USD | 3.39% |
| 2023 FY | 37.54 Billion USD | 17.47% |
| 2023 Q1 | 8.97 Billion USD | 8.03% |
| 2023 Q2 | 9.45 Billion USD | 5.37% |
| 2022 Q4 | 8.3 Billion USD | 3.84% |
| 2022 Q2 | 7.77 Billion USD | -1.35% |
| 2022 FY | 31.96 Billion USD | 27.94% |
| 2022 Q3 | 8 Billion USD | 2.92% |
| 2022 Q1 | 7.87 Billion USD | 6.67% |
| 2021 Q4 | 7.38 Billion USD | 20.9% |
| 2021 FY | 24.98 Billion USD | 17.18% |
| 2021 Q1 | 5.45 Billion USD | -7.29% |
| 2021 Q2 | 6.02 Billion USD | 10.5% |
| 2021 Q3 | 6.1 Billion USD | 1.33% |
| 2020 Q2 | 5.29 Billion USD | 7.24% |
| 2020 FY | 21.31 Billion USD | 9.53% |
| 2020 Q1 | 4.93 Billion USD | -6.66% |
| 2020 Q3 | 5.2 Billion USD | -1.57% |
| 2020 Q4 | 5.88 Billion USD | 13.0% |
| 2019 Q1 | 4.36 Billion USD | -8.74% |
| 2019 FY | 19.46 Billion USD | 13.46% |
| 2019 Q4 | 5.28 Billion USD | 4.57% |
| 2019 Q3 | 5.05 Billion USD | 6.2% |
| 2019 Q2 | 4.76 Billion USD | 9.12% |
| 2018 FY | 17.15 Billion USD | -5.47% |
| 2018 Q1 | 4.04 Billion USD | -11.16% |
| 2018 Q2 | 4.14 Billion USD | 2.45% |
| 2018 Q3 | 4.18 Billion USD | 1.06% |
| 2018 Q4 | 4.78 Billion USD | 14.16% |
| 2017 Q3 | 4.98 Billion USD | 21.51% |
| 2017 FY | 18.14 Billion USD | -3.86% |
| 2017 Q4 | 4.55 Billion USD | -8.65% |
| 2017 Q2 | 4.1 Billion USD | -9.09% |
| 2017 Q1 | 4.51 Billion USD | 1.94% |
| 2016 Q4 | 4.42 Billion USD | -7.79% |
| 2016 FY | 18.87 Billion USD | -5.91% |
| 2016 Q2 | 4.54 Billion USD | -11.15% |
| 2016 Q1 | 5.11 Billion USD | -0.37% |
| 2016 Q3 | 4.79 Billion USD | 5.68% |
| 2015 Q3 | 4.9 Billion USD | -6.41% |
| 2015 Q2 | 5.24 Billion USD | 9.44% |
| 2015 FY | 20.06 Billion USD | -0.94% |
| 2015 Q4 | 5.13 Billion USD | 4.61% |
| 2015 Q1 | 4.78 Billion USD | -4.55% |
| 2014 Q2 | 5.14 Billion USD | 3.71% |
| 2014 Q3 | 5.12 Billion USD | -0.39% |
| 2014 FY | 20.25 Billion USD | -0.96% |
| 2014 Q1 | 4.96 Billion USD | -8.16% |
| 2014 Q4 | 5.01 Billion USD | -2.17% |
| 2013 Q3 | 5.01 Billion USD | 1.97% |
| 2013 Q2 | 4.91 Billion USD | -3.99% |
| 2013 FY | 20.45 Billion USD | -9.43% |
| 2013 Q1 | 5.11 Billion USD | -13.0% |
| 2013 Q4 | 5.4 Billion USD | 7.82% |
| 2012 Q4 | 5.88 Billion USD | 8.8% |
| 2012 Q3 | 5.4 Billion USD | 1.77% |
| 2012 Q1 | 5.97 Billion USD | -15.19% |
| 2012 FY | 22.58 Billion USD | -18.08% |
| 2012 Q2 | 5.31 Billion USD | -11.05% |
| 2011 Q3 | 6.62 Billion USD | -4.72% |
| 2011 FY | 27.56 Billion USD | 2.55% |
| 2011 Q4 | 7.04 Billion USD | 6.4% |
| 2011 Q2 | 6.94 Billion USD | -0.07% |
| 2011 Q1 | 6.95 Billion USD | 1.39% |
| 2010 Q4 | 6.85 Billion USD | 7.59% |
| 2010 FY | 26.88 Billion USD | -0.55% |
| 2010 Q1 | 6.92 Billion USD | -4.92% |
| 2010 Q3 | 6.37 Billion USD | -5.23% |
| 2010 Q2 | 6.72 Billion USD | -2.83% |
| 2009 FY | 27.02 Billion USD | 8.1% |
| 2009 Q3 | 6.93 Billion USD | 6.82% |
| 2009 Q4 | 7.28 Billion USD | 4.94% |
| 2009 Q1 | 6.31 Billion USD | 3.9% |
| 2009 Q2 | 6.49 Billion USD | 2.79% |
| 2008 Q1 | 6.2 Billion USD | 2.95% |
| 2008 Q3 | 6.19 Billion USD | -5.13% |
| 2008 Q4 | 6.08 Billion USD | -1.76% |
| 2008 Q2 | 6.52 Billion USD | 5.12% |
| 2008 FY | 25 Billion USD | 6.15% |
| 2007 Q3 | 5.74 Billion USD | -1.02% |
| 2007 Q4 | 6.02 Billion USD | 4.94% |
| 2007 Q2 | 5.8 Billion USD | 4.35% |
| 2007 FY | 23.55 Billion USD | 12.62% |
| 2007 Q1 | 5.56 Billion USD | -0.25% |
| 2006 Q3 | 5.17 Billion USD | -1.09% |
| 2006 Q2 | 5.23 Billion USD | 6.19% |
| 2006 Q1 | 4.92 Billion USD | 0.63% |
| 2006 FY | 20.91 Billion USD | 12.49% |
| 2006 Q4 | 5.57 Billion USD | 7.71% |
| 2005 Q2 | 4.81 Billion USD | 11.22% |
| 2005 Q4 | 4.89 Billion USD | 7.79% |
| 2005 Q3 | 4.54 Billion USD | -5.71% |
| 2005 Q1 | 4.33 Billion USD | -0.25% |
| 2005 FY | 18.59 Billion USD | 14.54% |
| 2004 Q2 | 4.03 Billion USD | 3.09% |
| 2004 Q4 | 4.34 Billion USD | 9.17% |
| 2004 Q3 | 3.97 Billion USD | -1.44% |
| 2004 FY | 16.23 Billion USD | 12.89% |
| 2004 Q1 | 3.91 Billion USD | 2.57% |
| 2003 Q1 | 3.6 Billion USD | -1.73% |
| 2003 FY | 14.38 Billion USD | 7.9% |
| 2003 Q4 | 3.81 Billion USD | 5.8% |
| 2003 Q3 | 3.6 Billion USD | 7.81% |
| 2003 Q2 | 3.34 Billion USD | -7.17% |
| 2002 FY | 13.32 Billion USD | -43.46% |
| 2002 Q4 | 3.66 Billion USD | 17.96% |
| 2002 Q2 | 3.25 Billion USD | -0.15% |
| 2002 Q1 | 3.25 Billion USD | -71.69% |
| 2002 Q3 | 3.11 Billion USD | -4.35% |
| 2001 Q2 | 2.98 Billion USD | 2.73% |
| 2001 Q4 | 11.5 Billion USD | 298.68% |
| 2001 Q3 | 2.88 Billion USD | -3.38% |
| 2001 FY | 23.57 Billion USD | 30.11% |
| 2001 Q1 | 2.9 Billion USD | -55.11% |
| 2000 Q1 | 2.81 Billion USD | -44.93% |
| 2000 Q3 | 2.81 Billion USD | -4.86% |
| 2000 Q4 | 6.47 Billion USD | 129.73% |
| 2000 FY | 18.11 Billion USD | -1.74% |
| 2000 Q2 | 2.96 Billion USD | 5.22% |
| 1999 Q1 | 4.52 Billion USD | 139.56% |
| 1999 FY | 18.43 Billion USD | 101.57% |
| 1999 Q2 | 3.31 Billion USD | -26.71% |
| 1999 Q3 | 3.02 Billion USD | -8.69% |
| 1999 Q4 | 5.11 Billion USD | 69.0% |
| 1998 FY | 9.14 Billion USD | 6.52% |
| 1998 Q3 | 2.33 Billion USD | 50.68% |
| 1998 Q1 | 2.41 Billion USD | 5.66% |
| 1998 Q4 | 1.88 Billion USD | -19.0% |
| 1998 Q2 | 1.54 Billion USD | -36.03% |
| 1997 Q4 | 2.28 Billion USD | 8.99% |
| 1997 Q1 | 2.28 Billion USD | -49.88% |
| 1997 Q3 | 2.09 Billion USD | -8.08% |
| 1997 FY | 8.58 Billion USD | -6.51% |
| 1997 Q2 | 2.28 Billion USD | 0.0% |
| 1996 FY | 9.18 Billion USD | 21.35% |
| 1996 Q2 | 2.27 Billion USD | 0.0% |
| 1996 Q3 | 2.31 Billion USD | 1.54% |
| 1996 Q4 | 4.55 Billion USD | 96.97% |
| 1996 Q1 | 2.27 Billion USD | 29.2% |
| 1995 Q3 | 1.93 Billion USD | 80.99% |
| 1995 Q1 | 2.01 Billion USD | 10.43% |
| 1995 FY | 7.56 Billion USD | 8.06% |
| 1995 Q4 | 1.76 Billion USD | -8.86% |
| 1995 Q2 | 1.06 Billion USD | -47.0% |
| 1994 Q1 | 1.83 Billion USD | 19.77% |
| 1994 Q2 | 1.83 Billion USD | 0.0% |
| 1994 Q4 | 1.82 Billion USD | 4.21% |
| 1994 FY | 7 Billion USD | 6.64% |
| 1994 Q3 | 1.75 Billion USD | -4.57% |
| 1993 Q3 | 1.53 Billion USD | -12.1% |
| 1993 Q4 | 1.53 Billion USD | -0.22% |
| 1993 Q1 | 1.74 Billion USD | 0.0% |
| 1993 Q2 | 1.74 Billion USD | 0.0% |
| 1993 FY | 6.56 Billion USD | 8.83% |
| 1992 FY | 6.03 Billion USD | -17.91% |
| 1991 FY | 7.35 Billion USD | 0.04% |
| 1990 FY | 7.34 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amgen Inc. | 19.73 Billion USD | -90.197% |
| Biogen Inc. | 7.3 Billion USD | -414.133% |
| Gilead Sciences, Inc. | 21.14 Billion USD | -77.525% |
| MIRA Pharmaceuticals, Inc. | -8.52 Million USD | 440432.914% |
| Scilex Holding Company | 31.06 Million USD | -120764.722% |
| Scilex Holding Company | 31.06 Million USD | -120764.722% |